Revelation Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/08/2024 | Q3 2024 | -$0.84 | $0 | |||
| 08/09/2024 | Q2 2024 | -$5.13 | $0 | |||
| 05/10/2024 | Q1 2024 | -$2.46 | $0 | |||
| 03/22/2024 | Q4 2023 | -$8.33 | $37,574 | |||
| 11/09/2023 | Q3 2023 | -$12.52 | $0 | |||
| 08/11/2023 | Q2 2023 | -$7.47 | $0 | |||
| 05/22/2023 | Q1 2023 | $189.15 | $0 | |||
| 03/30/2023 | Q4 2022 | -$52.78 | $0 | |||
| 11/10/2022 | Q3 2022 | -$56.95 | $0 | |||
| 08/15/2022 | Q2 2022 | -$125.94 | $0 | |||
| 05/13/2022 | Q1 2022 | -$491.44 | $0 | |||
| 04/15/2022 | Q4 2021 | -$486.32 | $0 | |||
| 10/29/2021 | Q3 2021 | -$351.38 | $0 | |||
| 08/23/2021 | Q2 2021 | -$285.03 | $0 | |||
| 06/22/2021 | Q1 2021 | -$301.52 | $0 | |||
| 03/31/2021 | Q4 2020 | -$334.06 | $0 | |||
| 11/16/2020 | Q3 2020 | -$0.10 | $0 | |||
| 06/29/2020 | Q2 2020 | -$18.83 | $0 |
Revelation Biosciences, Inc. Earnings: Frequently Asked Questions
-
When is Revelation Biosciences, Inc.'s earnings date?
Revelation Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 30th, 2023 based off last year's report dates.
-
How can I listen to Revelation Biosciences, Inc.'s earnings conference call?
The conference call for Revelation Biosciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Revelation Biosciences, Inc.'s conference call transcript?
The conference call transcript for Revelation Biosciences, Inc.'s latest earnings report can be read online.
-
How much profit does Revelation Biosciences, Inc. generate each year?
Revelation Biosciences, Inc. (:REVBW) has a recorded net income of $0. Revelation Biosciences, Inc. has generated $-0.53 earnings per share over the last four quarters.
-
What is Revelation Biosciences, Inc.'s price-to-earnings ratio?
Revelation Biosciences, Inc. (:REVBW) has a price-to-earnings ratio of -0.13 and price/earnings-to-growth ratio is -0.
